Syllabus
Unit 1
Why Computational Drug Design? The Drug Discovery pipeline; Chemical Space; Cheminformatics and Virtual High Throughput Screening; Lipinski’s Rules of 5 and ADMET Modelling; Pharmacodynamics and pharmacokinetics; Structure-Based and Ligand-Based Drug Design.
Unit 2
Chemical File Formats and Representations; Topological Indices; Substructural Descriptors and 2D fingerprints; Local Molecular Surface Property Descriptors; 3D Shape and Chiral descriptors; Molecular Similarity Measures and Kernels; Chemical and Biological Networks.
Unit 3
Linear Free Energy Relationships; Pharmacophores and Molecular Interaction Fields; Model Validation; Structure Based Methods – Docking & Scoring; Molecular Simulation (Monte-Carlo, Molecular dynamics) – Structure and dynamics properties (normal mode analysis) – Gaussian and Gauss view – Density functional theory.
Unit 4
Linear and Non-Linear Models; Classification, Regression and Ranking; Data preprocessing, Performance Measures and unbalanced datasets; Dimensionality reduction and Feature selection; Evolutionary computing; Kernel methods; Best Practices in Predictive Modeling; Applications of Deep Learning in Pharma.
Objectives and Outcomes
Course Objectives
- To educate students on fundamentals stages of drug discovery pipeline and how computational and informatics techniques can accelerate the pace of drug discovery.
- To teach them how to encode a molecule into numerical molecular descriptors and strings, allowing computational treatment of molecules.
- Discuss drug-likeness, informatics approaches to the prediction of chemical properties – QSAR, pharmacophores, pharmacokinetics, and pharmacodynamics.
- To teach them how to apply AI / ML techniques and construct validated classification and regression models for biological endpoints.
Course Outcomes
After completing this course, students will be able to
CO1
|
Explain the drug discovery pipeline and the role of computational drug discovery in the process.
|
CO2
|
Construct SMILES Representations of Molecular Structures
|
CO3
|
Extract chemical information from Molecular Structures in different chemical file formats.
|
CO4
|
Compute different kinds of Molecular Descriptors and Fingerprints, and construct similarity kernels from them.
|
CO5
|
Construct validated Classification and Regression models for pharmacological endpoints and evaluate model performance and Domain of Applicability.
|
CO-PO Mapping
PO/PSO
|
PO1
|
PO2
|
PO3
|
PO4
|
PO5
|
PO6
|
PO7
|
PO8
|
PO9
|
PO10
|
PO11
|
PO12
|
PSO1
|
PSO2
|
PSO3
|
CO
|
CO1
|
3
|
3
|
2
|
–
|
–
|
2
|
2
|
3
|
–
|
1
|
1
|
1
|
–
|
–
|
2
|
CO2
|
2
|
3
|
3
|
–
|
2
|
–
|
–
|
–
|
–
|
1
|
–
|
1
|
2
|
–
|
–
|
CO3
|
2
|
3
|
3
|
–
|
2
|
–
|
–
|
–
|
–
|
1
|
–
|
1
|
2
|
–
|
–
|
CO4
|
3
|
2
|
2
|
2
|
3
|
–
|
–
|
1
|
1
|
–
|
–
|
2
|
2
|
2
|
–
|
CO5
|
2
|
1
|
3
|
3
|
3
|
–
|
–
|
1
|
1
|
1
|
–
|
2
|
3
|
3
|
2
|
Text Books / References
Text Books / References
Johann Gasteiger, Thomas Engel, Chemoinformatics: A Textbook (Wiley-VCH, 2003)
Jürgen Bajorath (Editor), Chemoinformatics and Computational Chemical Biology (Methods in Molecular Biology) (Humana Press, 2004)
Andrew R. & Leach, Valerie Gillet, An Introduction to Chemoinformatics (Springer International, New Delhi, 2009)
Merz Jr, K.M., Ringe, D. and Reynolds, C.H. (Editors) Drug design: structure-and ligand-based approaches (Cambridge University Press, 2010).
- Sukumar, et al, Computational Drug Discovery: A Primer (Ion Cure Press, 2023).
John L. Lamattina, Drug Truths: Dispelling the Myths about Pharma R&D (John Wiley, Hoboken, NJ, 2008)
Barry Werth, The Billion Dollar Molecule: One Company’s Quest for the Perfect Drug (Simon & Schuster, 1995)